5
198
M. A. Chari et al. / Tetrahedron Letters 51 (2010) 5195–5199
Table 3
135.10, 133.29, 129.91, 128.20, 127.78, 122.32, 121.62, 118.52,
Effect of the various solvents on the activity of the AlKIT-5 catalyst in the synthesis of
benzimidazoles
1
8 2 2
11.40. HRMS (EI) m/z calcd for C13H N Cl 262.0065, found
2
62.0068.
Name of the catalyst
Name of the solvent
Reaction time (h)
Yield (%)
Compound 3g: 2-(4-chlorophenyl)-1H-benzimidazole (Table
2):5 solid, mp 287–289 °C, IR (KBr):
m 3189, 2980, 1625 cm ; H
À1 1
AlKIT-5(10)
AlKIT-5(10)
AlKIT-5(10)
AlKIT-5(10)
Acetonitrile
Methanol
Ethanol
THF
4
4
4
4
95
94
89
80
NMR (DMSO-d
6
, 300 MHz): d 12.74 (br s, 1H), 8.17 (d, J = 9.0 Hz,
13
2
H), 7.62 (m, 1H), 7.60–7.57 (m, 3H), 7.22–7.19 (m, 2H);
C
NMR (DMSO-d
6
, 125 MHz): d 151.80, 143.75, 134.50, 130.12,
Reaction conditions: substrate = 1,2-phenylenediamine (1.2 mmol), benzaldehyde
1.0 mmol), amount of the AlKIT-5 catalyst = 150 mg, reaction temperature = reflux
temperature.
129.10, 128.20, 126.20, 122.32, 121.62, 118.52, 111.10. HRMS (EI)
m/z calcd for C13 Cl, 228.0454, found 228.0453.
Compound 3h: 2-(3-hydroxy phenyl)-1H-benzimidazole (Table
(
9 2
H N
À1
1
2): solid, mp 280–282 °C, IR (KBr):
m
3185, 2989, 1620 cm
; H
could also be used for several acid-catalyzed organic transforma-
tions and could replace the existing homogenous catalysts which
are hazardous and currently being used in the industry.
NMR (300 MHz, DMSO-d
6
): d 12.77 (br s, 1H), 9.69 (br s, OH),
7
.59–7.49 (m, 4H), 7.325 (s,1H), 7.17–7.20 (d, 2H), 6.88 (s, 1H);
1
3
C NMR (DMSO-d
31.38, 129.91, 122.37, 121.53, 118.76, 117.16, 116.89, 113.30,
O, 210.0793, found
6
, 125 MHz): d 157.71, 151.31, 143.71, 134.91,
1
2
. Experimental section
111.21. HRMS (EI) m/z calcd for C13
10.0799.
10 2
H N
2
All chemicals and solvents were obtained from Aldrich and used
Compound 3j: 2-(3,4-dimethoxy phenyl)-1H-benzimidazole
À1
without further purification. Column chromatographic separations
(Table 2): solid, mp 180–182 °C, IR (KBr):
m
3192, 2985, 1629 cm
;
1
1
were carried out on silica gel 100–200 mesh size. The H NMR
H NMR (DMSO-d6, 300 MHz): d 12.79 (br s, 1H), 7.68 (d, J =
spectra of samples were recorded on a JEOL 300-MHz NMR spec-
8.0 Hz, 1H), 7.28–7.21 (m, 2H), 7.1–7.0 (d, 1H), 6.83–6.73
13
3
trometer using TMS as an internal standard in CDCl . Mass spectra
were recorded on a MALDI-MS.
(m, 2H), 6.45–6.42 (d, J = 9.0 Hz, 1H), 3.81 (s, 3H); C NMR
(DMSO-d , 125 MHz): d 153.17, 150.06, 148.65, 135.97, 129.35,
122.31, 121.62, 121.58, 118.9, 111.97, 110.27, 55.8. HRMS (EI)
m/z calcd for C15 254.1055, found 254.1061.
Compound 3k: 2-benzyl-1H-benzimidazole (Table 2):
6
The AlKIT-5 materials with different nSi/nAl ratios were synthe-
sized using polymeric Pluronic F127 as a template, and tetraethyl
orthosilicate (TEOS) and aluminum isopropoxide as the sources
of silicon and aluminum, respectively. In a typical synthesis, plu-
ronic F127 (5 g) was dissolved in concd HCl (3 g, 35 wt %) and dis-
tilled water (240 g). To this mixture, TEOS (24 g) and the required
amount of the aluminum source were added, and the resulting
mixture was stirred for 24 h at 45 °C. Subsequently, the reaction
mixture was heated for 24 h at 100 °C under static condition for
hydrothermal treatment. After hydrothermal treatment, the final
solid product was filtered off and then dried at 100 °C without
washing. The white colored product was calcined at 540 °C for
14 2 2
H N O
21b
solid,
H NMR
, 300 MHz): d 12.22 (br s, 1H), 7.52 (d, J = 9.0 Hz, 1H),
7.37 (d, 1H), 7.31 (m, 4H), 7.22 (m, 1H), 7.10 (d, 2H), 4.14 (s,
–
1
1
mp 184–186 °C; IR (KBr): 3047, 2966, 1625 cm
(DMSO-d
;
6
1
3
6
2H); C NMR (DMSO-d , 125 MHz): d 153.44, 149.36, 143.33,
137.60, 128.69, 128.41, 126.44, 121.55, 120.87, 118.19, 110.85.
Compound 3m: 2-(2-naphthyl)-1H-benzimidazole (Table 2): so-
À1
1
lid, mp 212–215 °C, IR (KBr):
m 3155, 2925, 2853, 1624 cm ; H
1
NMR (DMSO-d
13.02 (br s, 1H), 8.72 (br s, 1H), 8.32 (dd, J = 8.0, 2.0 Hz, 1H),
8.08–7.96 (m, 3H), 7.68–7.57 (m, 4H), 7.24–7.21 (m, 2H); 13
NMR (DMSO-d , 125 MHz): d 151.17, 133.38, 132.75, 128.45,
28.35, 127.71, 127.55, 127.01, 126.82, 125.73, 123.87.
Compound 3p: 5-methyl-2-phenyl-benzimidazole (Table 2):2
6 6
, 300 MHz): H NMR (DMSO-d , 300 MHz): d
1
0 h. The samples are denoted as AlKIT-5(x) where x denotes the
C
nSi/nAl ratio in the final product.
6
1
2a
2.1. General reaction procedure
solid, mp 243–245 °C. IR (KBr):
m
3262, 1745, 1586, 1445, 1261,
–
1
1
To a mixture of an aldehyde (1.0 mmol) and 1,2-phenylenedi-
1115, 969, 746 cm
;
6
H NMR (DMSO-d , 300 MHz): d 12.72 (br
amine (1.2 mmol) in acetonitrile (5 mL) under open air atmo-
sphere, AlKIT-5 (150 mg) was added. The resulting mixture was
stirred at reflux temperature for appropriate time (Table 2). After
completion of the reaction, as monitored by TLC, the reaction mix-
ture was diluted with ethyl acetate (20 mL) and the catalyst was
separated by filtration. The organic layer was concentrated under
reduced pressure and the crude product was purified by silica gel
column chromatography using ethyl acetate–n-hexane (1:9) as
s, 1H), 8.13 (d, J = 6.9 Hz, 2H), 7.45–7.55 (m, 5H), 7.00 (d,
J = 7.0 Hz, 1H), 2.41 (s, 3H); C NMR (DMSO-d , 125 MHz): d
6
1
3
151.3, 130.3 (3C), 129.7, 128.8, 128.9 (2C), 126.35 (2C), 126.25
(3C), 21.8.
Compound 3q: 5-chloro-2-phenyl-benzimidazole (Table 2):22b
solid, mp 212–214 °C. IR (KBr): 3580, 2918, 1580, 1430, 1270,
–
1
1
1108, 805, 693 cm
6
; H NMR (DMSO-d , 300 MHz): d 13.1 (br s,
1H), 8.15 (d, J = 8.0 Hz, 2H), 7.68–7.58 (m, 1H), 7.57–7.47 (m,
1
3
eluent to afford the pure benzimidazole. The spectral data are in
4H), 7.23–7.22 (dd, J = 8.0, 1.6 Hz, 1H);
6
C NMR (DMSO-d ,
full agreement with the data reported in the literature.5
tral data for the selected products:
,21,22
Spec-
125 MHz): d 153.0 (4C), 130.25, 129.6, 128.9 (2C), 126.5 (2C),
122.25 (3C). HRMS (EI) m/z calcd for C13H N Cl 228.0454, found
9 2
228.0458.
22a
Compound 3a: 2-phenyl-1H-benzimidazole (Table 2):
3a: 2-
21a
phenyl-1H-benzimidazole (Table 2):
047, 2966, 1462, 1411, 1276, 970, 744, 703 cm–1
300 MHz, DMSO-d ): d 12.89 (br s, 1H), 8.15–8.18 (m, 2H), 7.54
d, 1H) 7.50–7.54 (m, 4H), 7.19–7.20 (d, 2H); C NMR (DMSO-d
Solid, mp 293 °C, IR (KBr):
Compound 3r: 5-nitro-2-phenyl-benzimidazole (Table 2): solid,
mp 208–210 °C, IR (KBr): 3423, 3081, 1642, 1563, 1539, 1328,
, 300 MHz): d 9.50 (br s, 1H, NH), 8.46 (d,
J = 1.8 Hz, 1H), 8.20–8.18 (m, 2H), 8.12 (dd, J = 7.8, 1.8 Hz, 1H),
1
3
;
H NMR
m
1
(
(
6
758; H NMR (DMSO-d
6
13
6
,
1
3
1
1
1
25 MHz): d 151.8, 143.75, 134.96, 130.12, 129.7, 128.88, 126.39,
7.75 (d, J = 7.8 Hz, 1H), 7.59–7.57 (m, 3H, ArH); C NMR (DMSO-
6
d , 125 MHz): d 155.8 (3C), 142.7, 131.0, 129.1, 129.0 (2C), 127.0
22.47, 121.62, 118.82, 111.26. HRMS (EI) m/z calcd for C13
H
10
N
2
94.0000, found 194.0004.
(2C), 118.0 (3C).
Compound 3f: 2-(2,4-dichlorophenyl)-1H-benzimidazole (Table
À1
2
): solid, mp À218 to 220 °C, IR (KBr):
m
3192, 2984, 1622 cm
;
Acknowledgments
1
6
H NMR (DMSO-d , 300 MHz): d 12.41 (br s, 1H), 7.92 (d,
J = 9.0 Hz, 2H), 7.82 (m, 1H), 7.64–7.58 (m, 3H), 7.25–7.22 (m,
This work was financially supported by the Ministry of Educa-
tion, Culture, Sports, Science and Technology (MEXT) under the
1
3
2
6
H); C NMR (DMSO-d , 125 MHz): d 151.88, 148.80, 143.75,